BioCentury
ARTICLE | Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

October 12, 2015 7:00 AM UTC

Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP), New York, N.Y. Business: Cancer, Neurology, Autoimmune Date completed: 2015-10-01 Type: Private placement of convertible preferred stock Raised: $3...